Annual FCF
-$36.78 M
-$5.50 M-17.58%
01 June 2022
Summary:
Pluristem Therapeutics annual free cash flow is currently -$36.78 million, with the most recent change of -$5.50 million (-17.58%) on 01 June 2022. During the last 3 years, it has fallen by -$5.50 million (-17.58%).PSTI Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$7.68 M
+$944.00 K+10.94%
01 September 2022
Summary:
Pluristem Therapeutics quarterly free cash flow is currently -$7.68 million, with the most recent change of +$944.00 thousand (+10.94%) on 01 September 2022.PSTI Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$35.66 M
+$1.12 M+3.05%
01 September 2022
Summary:
Pluristem Therapeutics TTM free cash flow is currently -$35.66 million, with the most recent change of +$1.12 million (+3.05%) on 01 September 2022.PSTI TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -17.6% | +12.7% | -5.3% |
| 5 y5 years | -23.9% | -5.3% | -26.0% |
PSTI Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | >+9999.0% | -171.1% | -430.3% |
Pluristem Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$7.68 M(-10.9%) | -$35.66 M(-3.1%) |
| June 2022 | -$36.78 M(+17.6%) | -$8.63 M(-8.8%) | -$36.78 M(-2.7%) |
| Mar 2022 | - | -$9.46 M(-4.4%) | -$37.79 M(+5.6%) |
| Dec 2021 | - | -$9.89 M(+12.4%) | -$35.79 M(+5.7%) |
| Sept 2021 | - | -$8.80 M(-8.7%) | -$33.87 M(+8.3%) |
| June 2021 | -$31.28 M(+17.4%) | -$9.64 M(+29.3%) | -$31.28 M(+11.4%) |
| Mar 2021 | - | -$7.45 M(-6.5%) | -$28.08 M(+3.4%) |
| Dec 2020 | - | -$7.97 M(+28.2%) | -$27.16 M(+6.3%) |
| Sept 2020 | - | -$6.22 M(-3.4%) | -$25.56 M(-4.0%) |
| June 2020 | -$26.64 M(-10.3%) | -$6.43 M(-1.5%) | -$26.64 M(-1.0%) |
| Mar 2020 | - | -$6.53 M(+2.5%) | -$26.90 M(+1.9%) |
| Dec 2019 | - | -$6.38 M(-12.6%) | -$26.40 M(-6.7%) |
| Sept 2019 | - | -$7.29 M(+9.0%) | -$28.30 M(-4.7%) |
| June 2019 | -$29.69 M(+36.7%) | -$6.70 M(+11.0%) | -$29.69 M(+2.7%) |
| Mar 2019 | - | -$6.03 M(-27.2%) | -$28.91 M(+1.5%) |
| Dec 2018 | - | -$8.28 M(-4.7%) | -$28.48 M(+13.6%) |
| Sept 2018 | - | -$8.69 M(+47.0%) | -$25.07 M(+15.4%) |
| June 2018 | -$21.72 M(-1.2%) | -$5.91 M(+5.3%) | -$21.72 M(-2.2%) |
| Mar 2018 | - | -$5.61 M(+15.3%) | -$22.22 M(+0.0%) |
| Dec 2017 | - | -$4.87 M(-8.9%) | -$22.22 M(-4.5%) |
| Sept 2017 | - | -$5.34 M(-16.7%) | -$23.26 M(+5.8%) |
| June 2017 | -$21.99 M(+8.5%) | -$6.41 M(+14.2%) | -$21.99 M(+3.0%) |
| Mar 2017 | - | -$5.61 M(-5.0%) | -$21.34 M(-0.2%) |
| Dec 2016 | - | -$5.90 M(+45.1%) | -$21.38 M(+9.9%) |
| Sept 2016 | - | -$4.07 M(-29.4%) | -$19.47 M(-4.0%) |
| June 2016 | -$20.27 M(-5.4%) | -$5.76 M(+1.9%) | -$20.27 M(+2.8%) |
| Mar 2016 | - | -$5.65 M(+41.8%) | -$19.72 M(-4.8%) |
| Dec 2015 | - | -$3.99 M(-18.2%) | -$20.72 M(-8.3%) |
| Sept 2015 | - | -$4.87 M(-6.4%) | -$22.58 M(+5.4%) |
| June 2015 | -$21.44 M(+3.6%) | -$5.21 M(-21.6%) | -$21.44 M(-1.3%) |
| Mar 2015 | - | -$6.65 M(+13.6%) | -$21.72 M(+3.4%) |
| Dec 2014 | - | -$5.85 M(+57.0%) | -$21.00 M(+11.3%) |
| Sept 2014 | - | -$3.73 M(-32.2%) | -$18.86 M(-8.8%) |
| June 2014 | -$20.69 M(-2.4%) | -$5.49 M(-7.3%) | -$20.69 M(-2.7%) |
| Mar 2014 | - | -$5.92 M(+59.3%) | -$21.28 M(+5.1%) |
| Dec 2013 | - | -$3.72 M(-33.1%) | -$20.24 M(-4.7%) |
| Sept 2013 | - | -$5.56 M(-8.5%) | -$21.25 M(+0.3%) |
| June 2013 | -$21.20 M(+345.8%) | -$6.08 M(+24.2%) | -$21.20 M(+30.7%) |
| Mar 2013 | - | -$4.89 M(+3.5%) | -$16.22 M(+14.5%) |
| Dec 2012 | - | -$4.73 M(-14.0%) | -$14.16 M(+4.6%) |
| Sept 2012 | - | -$5.50 M(+401.4%) | -$13.54 M(+184.7%) |
| June 2012 | -$4.75 M | -$1.10 M(-61.3%) | -$4.75 M(-22.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$2.84 M(-30.9%) | -$6.11 M(+28.3%) |
| Dec 2011 | - | -$4.10 M(-225.0%) | -$4.76 M(+105.1%) |
| Sept 2011 | - | $3.28 M(-234.0%) | -$2.32 M(-65.4%) |
| June 2011 | -$6.72 M(+15.9%) | -$2.45 M(+64.5%) | -$6.72 M(+9.3%) |
| Mar 2011 | - | -$1.49 M(-10.6%) | -$6.14 M(-6.2%) |
| Dec 2010 | - | -$1.67 M(+49.5%) | -$6.55 M(+10.7%) |
| Sept 2010 | - | -$1.11 M(-40.6%) | -$5.92 M(+2.1%) |
| June 2010 | -$5.80 M(+26.7%) | -$1.88 M(-0.9%) | -$5.80 M(+16.9%) |
| Mar 2010 | - | -$1.89 M(+83.2%) | -$4.96 M(+15.1%) |
| Dec 2009 | - | -$1.03 M(+4.2%) | -$4.30 M(+20.3%) |
| Sept 2009 | - | -$992.00 K(-4.3%) | -$3.58 M(-21.8%) |
| June 2009 | -$4.58 M(-14.9%) | -$1.04 M(-16.5%) | -$4.58 M(-13.8%) |
| Mar 2009 | - | -$1.24 M(+303.2%) | -$5.31 M(+7.8%) |
| Dec 2008 | - | -$308.00 K(-84.5%) | -$4.92 M(-16.8%) |
| Sept 2008 | - | -$1.99 M(+12.2%) | -$5.92 M(+10.1%) |
| June 2008 | -$5.38 M(+60.0%) | -$1.77 M(+106.8%) | -$5.38 M(+6.9%) |
| Mar 2008 | - | -$857.00 K(-34.1%) | -$5.03 M(-0.3%) |
| Dec 2007 | - | -$1.30 M(-10.1%) | -$5.04 M(+22.7%) |
| Sept 2007 | - | -$1.45 M(+1.7%) | -$4.11 M(+22.2%) |
| June 2007 | -$3.36 M(+60.4%) | -$1.42 M(+63.3%) | -$3.36 M(+31.6%) |
| Mar 2007 | - | -$871.00 K(+137.3%) | -$2.55 M(+11.2%) |
| Dec 2006 | - | -$367.00 K(-47.6%) | -$2.30 M(-2.4%) |
| Sept 2006 | - | -$701.00 K(+13.9%) | -$2.35 M(+12.3%) |
| June 2006 | -$2.10 M(+12.6%) | -$615.40 K(+0.4%) | -$2.10 M(+5.7%) |
| Mar 2006 | - | -$612.70 K(+44.7%) | -$1.98 M(-3.2%) |
| Dec 2005 | - | -$423.40 K(-4.6%) | -$2.05 M(+10.5%) |
| Sept 2005 | - | -$443.90 K(-11.7%) | -$1.85 M(-0.4%) |
| June 2005 | -$1.86 M(+13.6%) | -$502.50 K(-25.8%) | -$1.86 M(+4.0%) |
| Mar 2005 | - | -$677.50 K(+195.5%) | -$1.79 M(+11.6%) |
| Dec 2004 | - | -$229.30 K(-49.2%) | -$1.60 M(-9.5%) |
| Sept 2004 | - | -$451.50 K(+4.6%) | -$1.77 M(+8.2%) |
| June 2004 | -$1.64 M(+321.7%) | -$431.60 K(-12.1%) | -$1.64 M(+9.3%) |
| Mar 2004 | - | -$491.00 K(+23.3%) | -$1.50 M(+39.5%) |
| Dec 2003 | - | -$398.20 K(+25.8%) | -$1.07 M(+55.8%) |
| Sept 2003 | - | -$316.60 K(+8.3%) | -$689.00 K(+77.4%) |
| June 2003 | -$388.30 K(+504.8%) | -$292.30 K(+339.5%) | -$388.30 K(+270.2%) |
| Mar 2003 | - | -$66.50 K(+389.0%) | -$104.90 K(+72.2%) |
| Dec 2002 | - | -$13.60 K(-14.5%) | -$60.90 K(-100.6%) |
| Sept 2002 | - | -$15.90 K(+78.7%) | $10.75 M(-0.1%) |
| June 2002 | -$64.20 K | -$8900.00(-60.4%) | $10.77 M(-0.1%) |
| Mar 2002 | - | -$22.50 K(-100.2%) | $10.77 M(-0.2%) |
| Dec 2001 | - | $10.80 M | $10.80 M |
FAQ
- What is Pluristem Therapeutics annual free cash flow?
- What is the all time high annual FCF for Pluristem Therapeutics?
- What is Pluristem Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Pluristem Therapeutics?
- What is Pluristem Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Pluristem Therapeutics?
What is Pluristem Therapeutics annual free cash flow?
The current annual FCF of PSTI is -$36.78 M
What is the all time high annual FCF for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual free cash flow is -$64.20 K
What is Pluristem Therapeutics quarterly free cash flow?
The current quarterly FCF of PSTI is -$7.68 M
What is the all time high quarterly FCF for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly free cash flow is $10.80 M
What is Pluristem Therapeutics TTM free cash flow?
The current TTM FCF of PSTI is -$35.66 M
What is the all time high TTM FCF for Pluristem Therapeutics?
Pluristem Therapeutics all-time high TTM free cash flow is $10.80 M